Recent studies implicate the lymphocyte integrin alpha4Beta7 as a 'homing receptor' for the mucosal vascular addressin MAdCAM-1, a vascular Ig- family member that defines sites of lymphocyte extravasation into mucosal microenvironments. Our overall goal is to define the importance of alpha4Beta7 in the pathology and physiology of mucosal immunity and inflammation, and its role in the systemic segregation of mucosal from nonmucosal immune systems.
Specific Aims i nclude: 1) To determine if alpha4Beta7 expression by lymphocyte subsets correlates with and predicts their binding to MAdCAM-1, and their in vivo trafficking to mucosal tissues and to inflamed gut in models of intestinal inflammatory disease. Adhesion of circulating lymphocytes to MAdCAM-1 (and for comparison to VCAM-1) will be correlated with lineage, memory vs. naive phenotype, and expression of alpha4Beta7 (vs alpha4Beta1). Animal models will be used to measure the capacity of alpha4Beta7hi vs. alpha4Beta7 memory cells to home to and recirculate through mucosal vs. peripheral tissues. 2) To test the hypothesis that alpha4Beta7hi CD45R0+ T cells comprise T cell memory for intestinal recall antigens: Human PBL will be FACS sorted to isolate CD45RA-CD4+ 'memory' T cells of presumptive mucosal (alpha4Beta7hi) vs. nonmucosal (alpha4Beta7-) phenotypes, and each fraction will be assayed in vitro for recall responses to the ubiquitous intestinal pathogen rotavirus. 3) In situ videomicroscopy will be used to analyze directly the role of alpha4Beta7 in lymphocyte attachment, rolling and activation-dependent arrest in Peyer's patch-high endothelial venules (HEV); and in the venules of the small intestinal lamina propria. These in vivo studies are critical to understanding the mechanism by which alpha4Beta7 regulates lymphocyte trafficking to mucosal sites in conjunction with other adhesion and activating receptors. 4) Immunohistologic and flow cytometric approaches will be used to study the regulation of alpha4Beta7 during ontogeny and lymphocyte differentiation; and in chronic inflammation in mucosal vs. other tissues, especially in inflammatory bowel disease in man, or in intestinal inflammatory models in mice. 5) MAb and peptide inhibition studies will be carried out to determine whether alpha4Beta7 recognition of its known ligands (MAdCAM-1, VCAM-1, fibronectin), and alpha4Beta7 participation in lymphocyte aggregation, involve distinct or overlapping integrin epitopes or peptide binding pockets. 6) Lymphocyte binding to immunoisolated alpha4 monomer and to alpha4-derived peptides will be assayed to determine the ability of the alpha4 integrin chain to serve as a substrate for alpha4Beta7 (and alpha4Beta7) adhesion, and to define the peptide sequences involved. Functional studies of transfectants expressing mutated alpha4 will assess its role as a ligand in lymphocyte aggregation and in immune cell interactions. Taken together, the proposed studies should help define the roles of alpha4Beta7 in mucosal lymphocyte trafficking and immune responses, and in pathologic inflammatory diseases. They may lead to novel approaches to regulating pathologic immune and inflammatory reactions in inflammatory bowel disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI037832-01
Application #
2074707
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1995-04-01
Project End
2000-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Stanford University
Department
Pathology
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Zabel, Brian A; Zuniga, Luis; Ohyama, Takao et al. (2006) Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol 34:1021-32
Zabel, Brian A; Silverio, Amanda M; Butcher, Eugene C (2005) Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 174:244-51
Zabel, Brian A; Allen, Samantha J; Kulig, Paulina et al. (2005) Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 280:34661-6
Lazarus, Nicole H; Kunkel, Eric J; Johnston, Brent et al. (2003) A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J Immunol 170:3799-805
Bowman, Edward P; Kuklin, Nelly A; Youngman, Kenneth R et al. (2002) The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J Exp Med 195:269-75
Kruse, Andrea; Martens, Nicole; Fernekorn, Uta et al. (2002) Alterations in the expression of homing-associated molecules at the maternal/fetal interface during the course of pregnancy. Biol Reprod 66:333-45
Roy, Meenakshi P; Kim, Chang H; Butcher, Eugene C (2002) Cytokine control of memory B cell homing machinery. J Immunol 169:1676-82
Kunkel, Eric J; Boisvert, Judie; Murphy, Kristine et al. (2002) Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 160:347-55
Kim, Chang H; Johnston, Brent; Butcher, Eugene C (2002) Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity. Blood 100:11-6
Llave, Cesar; Kasschau, Kristin D; Rector, Maggie A et al. (2002) Endogenous and silencing-associated small RNAs in plants. Plant Cell 14:1605-19

Showing the most recent 10 out of 33 publications